Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Arterenol
2. Levarterenol
3. Levonor
4. Levonorepinephrine
5. Levophed
6. Levophed Bitartrate
7. Noradrnaline Tartrate Renaudin
8. Noradrenaline
9. Noradrenaline Bitartrate
10. Norepinephrin D-tartrate (1:1)
11. Norepinephrine
12. Norepinephrine Bitartrate
13. Norepinephrine D-tartrate (1:1)
14. Norepinephrine Hydrochloride
15. Norepinephrine Hydrochloride, (+)-isomer
16. Norepinephrine Hydrochloride, (+,-)-isomer
17. Norepinephrine L-tartrate (1:1)
18. Norepinephrine L-tartrate (1:1), (+,-)-isomer
19. Norepinephrine L-tartrate (1:1), Monohydrate
20. Norepinephrine L-tartrate (1:1), Monohydrate, (+)-isomer
21. Norepinephrine L-tartrate (1:2)
22. Norepinephrine L-tartrate, (+)-isomer
23. Norepinephrine, (+)-isomer
24. Norepinephrine, (+,-)-isomer
1. Noradrenaline Bitartrate
2. 51-40-1
3. Noradrenalinebitartrate
4. Norepinephrine (tartrate)
5. Noradrenaline Acid Tartrate
6. L-norepinephrine Bitartrate
7. L-arterenol Bitartrate
8. L-noradrenaline Tartrate
9. Norartrinal Bitartrate
10. 3414-63-9
11. Norepinephrine Tartrate
12. L-noradrenaline D-bitartrate
13. (-)-norepinephrine Bitartrate
14. Noradrenaline Hydrogen Tartrate
15. Noradrenaline, Tartrate (1:1)
16. Nsc-169106
17. Levophed Bitartrate
18. Noradrealine
19. L-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol Bitartrate
20. (+)-hydrogentartratebitartratesalt
21. Arterenol,hydrate
22. Arterenol, Hydrate
23. (-)-noradrenaline Tartrate
24. (-)-norepinephrine Tartrate
25. Schembl41601
26. (-)-arterenol Bitartrate Salt
27. Chembl2062273
28. (-)-noradrenaline Acid Tartrate
29. Bcbcmap01_000135
30. Norepinephrine Tartrate Impurity 1
31. Amy33378
32. Bcp31352
33. Nsc60394
34. (-)-noradrenaline Hydrogen Tartrate
35. (-)-norepinephrine (+)-bitartrate
36. Wln: Z1yqr Cq Dq &ovyqyqvo
37. Nsc-60394
38. Nsc169106
39. Akos015895170
40. L-(-)-norepinephrine (+)-bitartrate
41. Smp1_000021
42. (-)-noradrenaline Bitartrate Monohydrate
43. Ac-18753
44. Db-073364
45. N-8721
46. Sr-01000075279-1
47. Benzyl Alcohol,4-dihydroxy-, (-)-, Tartrate (1:1)
48. D-norepinephrine D-bitartrate;(+)-noradrenaline Bitartrate
49. L-(-)-norepinephrine-(+)-bitartrate - Cas 69815-49-2
50. Benzyl Alcohol,4-dihydroxy-, (-)-, Tartrate (1:1) (salt)
51. 4-(2-amino-1-hydroxyethyl)benzene-1,2-diol;2,3-dihydroxybutanedioic Acid
52. 1, 4-(2-amino-1-hydroxyethyl)-, (r)-, [r-(r*,r*)]-2,3-dihydroxybutanedioate (1:1) (salt)
Molecular Weight | 319.26 g/mol |
---|---|
Molecular Formula | C12H17NO9 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 5 |
Exact Mass | 319.09033112 g/mol |
Monoisotopic Mass | 319.09033112 g/mol |
Topological Polar Surface Area | 202 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 276 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 3 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Adrenergic alpha-Agonists
Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
33
PharmaCompass offers a list of Noradrenaline Bitartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Noradrenaline Bitartrate manufacturer or Noradrenaline Bitartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Noradrenaline Bitartrate manufacturer or Noradrenaline Bitartrate supplier.
PharmaCompass also assists you with knowing the Noradrenaline Bitartrate API Price utilized in the formulation of products. Noradrenaline Bitartrate API Price is not always fixed or binding as the Noradrenaline Bitartrate Price is obtained through a variety of data sources. The Noradrenaline Bitartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Noradrenaline Bitartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Noradrenaline Bitartrate, including repackagers and relabelers. The FDA regulates Noradrenaline Bitartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Noradrenaline Bitartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Noradrenaline Bitartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Noradrenaline Bitartrate supplier is an individual or a company that provides Noradrenaline Bitartrate active pharmaceutical ingredient (API) or Noradrenaline Bitartrate finished formulations upon request. The Noradrenaline Bitartrate suppliers may include Noradrenaline Bitartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Noradrenaline Bitartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Noradrenaline Bitartrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Noradrenaline Bitartrate active pharmaceutical ingredient (API) in detail. Different forms of Noradrenaline Bitartrate DMFs exist exist since differing nations have different regulations, such as Noradrenaline Bitartrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Noradrenaline Bitartrate DMF submitted to regulatory agencies in the US is known as a USDMF. Noradrenaline Bitartrate USDMF includes data on Noradrenaline Bitartrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Noradrenaline Bitartrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Noradrenaline Bitartrate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Noradrenaline Bitartrate Drug Master File in Korea (Noradrenaline Bitartrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Noradrenaline Bitartrate. The MFDS reviews the Noradrenaline Bitartrate KDMF as part of the drug registration process and uses the information provided in the Noradrenaline Bitartrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Noradrenaline Bitartrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Noradrenaline Bitartrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Noradrenaline Bitartrate suppliers with KDMF on PharmaCompass.
A Noradrenaline Bitartrate CEP of the European Pharmacopoeia monograph is often referred to as a Noradrenaline Bitartrate Certificate of Suitability (COS). The purpose of a Noradrenaline Bitartrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Noradrenaline Bitartrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Noradrenaline Bitartrate to their clients by showing that a Noradrenaline Bitartrate CEP has been issued for it. The manufacturer submits a Noradrenaline Bitartrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Noradrenaline Bitartrate CEP holder for the record. Additionally, the data presented in the Noradrenaline Bitartrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Noradrenaline Bitartrate DMF.
A Noradrenaline Bitartrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Noradrenaline Bitartrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Noradrenaline Bitartrate suppliers with CEP (COS) on PharmaCompass.
A Noradrenaline Bitartrate written confirmation (Noradrenaline Bitartrate WC) is an official document issued by a regulatory agency to a Noradrenaline Bitartrate manufacturer, verifying that the manufacturing facility of a Noradrenaline Bitartrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Noradrenaline Bitartrate APIs or Noradrenaline Bitartrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Noradrenaline Bitartrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Noradrenaline Bitartrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Noradrenaline Bitartrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Noradrenaline Bitartrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Noradrenaline Bitartrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Noradrenaline Bitartrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Noradrenaline Bitartrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Noradrenaline Bitartrate suppliers with NDC on PharmaCompass.
Noradrenaline Bitartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Noradrenaline Bitartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Noradrenaline Bitartrate GMP manufacturer or Noradrenaline Bitartrate GMP API supplier for your needs.
A Noradrenaline Bitartrate CoA (Certificate of Analysis) is a formal document that attests to Noradrenaline Bitartrate's compliance with Noradrenaline Bitartrate specifications and serves as a tool for batch-level quality control.
Noradrenaline Bitartrate CoA mostly includes findings from lab analyses of a specific batch. For each Noradrenaline Bitartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Noradrenaline Bitartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Noradrenaline Bitartrate EP), Noradrenaline Bitartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Noradrenaline Bitartrate USP).